Loading clinical trials...
Loading clinical trials...
The primary objective of this trial is to understand the mechanism of action of BI655130 in patients with UC Secondary objectives are to explore clinical effect, safety and tolerability (including im...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Boehringer Ingelheim
NCT06294925 · Colitis, Ulcerative
NCT05076175 · Colitis, Ulcerative
NCT06359808 · Colitis, Ulcerative, Sleep Quality, and more
NCT06651281 · Crohn Disease, Colitis, Ulcerative
NCT04121806 · Colitis, Ulcerative
UZ Leuven
Leuven
Asklepios Kliniken Westklinikum Hamburg
Hamburg
Universitätsklinikum Schleswig-Holstein, Campus Kiel
Kiel
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions